Chinese guidelines for diagnosis and treatment of primary lung cancer 2018 (English version)
- PMID: 30996564
- PMCID: PMC6433582
- DOI: 10.21147/j.issn.1000-9604.2019.01.01
Chinese guidelines for diagnosis and treatment of primary lung cancer 2018 (English version)
Similar articles
-
Chinese guidelines for diagnosis and treatment of gastric cancer 2018 (English version).Chin J Cancer Res. 2019 Oct;31(5):707-737. doi: 10.21147/j.issn.1000-9604.2019.05.01. Chin J Cancer Res. 2019. PMID: 31814675 Free PMC article. No abstract available.
-
Chinese guidelines for diagnosis and treatment of cervical cancer 2018 (English version).Chin J Cancer Res. 2019 Apr;31(2):295-305. doi: 10.21147/j.issn.1000-9604.2019.02.04. Chin J Cancer Res. 2019. PMID: 31156300 Free PMC article. No abstract available.
-
Chinese guidelines for diagnosis and treatment of pancreatic cancer 2018 (English version).Chin J Cancer Res. 2019 Apr;31(2):278-294. doi: 10.21147/j.issn.1000-9604.2019.02.03. Chin J Cancer Res. 2019. PMID: 31156299 Free PMC article. No abstract available.
-
[Normativity of overview report of the systematic review of acupuncture and moxibustion at home and abroad based on PRIO-harms scale].Zhongguo Zhen Jiu. 2020 Jul 12;40(7):793-8. doi: 10.13703/j.0255-2930.20190508-k0004. Zhongguo Zhen Jiu. 2020. PMID: 32648407 Chinese.
-
Practice guidelines for the pathological diagnosis of primary liver cancer: 2015 update.World J Gastroenterol. 2016 Nov 14;22(42):9279-9287. doi: 10.3748/wjg.v22.i42.9279. World J Gastroenterol. 2016. PMID: 27895416 Free PMC article. Review.
Cited by
-
Lung adenocarcinoma relapse with emerging EGFR mutation following complete response of small cell lung cancer warrants routine re-biopsy: A case report.Front Oncol. 2022 Oct 26;12:1024655. doi: 10.3389/fonc.2022.1024655. eCollection 2022. Front Oncol. 2022. PMID: 36387208 Free PMC article.
-
Evaluation of the reporting quality of clinical practice guidelines on lung cancer using the RIGHT checklist.Transl Lung Cancer Res. 2021 Jun;10(6):2588-2602. doi: 10.21037/tlcr-21-405. Transl Lung Cancer Res. 2021. PMID: 34295664 Free PMC article.
-
Consistency of recommendations for the diagnosis and treatment of non-small cell lung cancer: a systematic review.Transl Lung Cancer Res. 2021 Jun;10(6):2715-2732. doi: 10.21037/tlcr-21-423. Transl Lung Cancer Res. 2021. PMID: 34295672 Free PMC article. Review.
-
Real-world clinical practice and outcomes in treating stage III non-small cell lung cancer: KINDLE-Asia subset.Front Oncol. 2023 Mar 27;13:1117348. doi: 10.3389/fonc.2023.1117348. eCollection 2023. Front Oncol. 2023. PMID: 37051534 Free PMC article.
-
Lipidomics reveals that sustained SREBP-1-dependent lipogenesis is a key mediator of gefitinib-acquired resistance in EGFR-mutant lung cancer.Cell Death Discov. 2021 Nov 13;7(1):353. doi: 10.1038/s41420-021-00744-1. Cell Death Discov. 2021. PMID: 34775471 Free PMC article.
LinkOut - more resources
Full Text Sources